Anti-GLRX / Glutaredoxin 1

0.5mg/ml if reconstituted with 0.2ml sterile DI water. GLRX (Glutaredoxin 1) is a small redox enzyme that belongs to the thioredoxin family and plays an essential role in maintaining cellular redox homeostasis. It catalyzes the reversible reduction of protein disulfides and mixed disulfides formed between proteins and glutathione, a process known as deglutathionylation. This activity regulates protein function, protects against oxidative stress, and ensures proper signal transduction. Researchers frequently use a GLRX antibody to investigate antioxidant defense systems, redox regulation, and stress responses. GLRX is widely expressed in mammalian tissues, with particularly high levels in heart, liver, and skeletal muscle. Its enzymatic activity is critical in pathways that counteract oxidative damage and maintain the thiol status of proteins. Dysregulation of GLRX has been linked to cardiovascular disease, neurodegenerative disorders, and cancer, where imbalances in redox signaling contribute to disease pathology. Employing a GLRX antibody allows scientists to analyze protein expression, localization, and post-translational modifications in health and disease. In addition to its protective role, GLRX has been implicated in apoptosis, inflammatory responses, and mitochondrial function. It also interacts with iron-sulfur cluster proteins, influencing mitochondrial biogenesis and energy metabolism. Because oxidative stress is a common hallmark of many diseases, GLRX remains an attractive target for translational research. Using a GLRX antibody provides a reliable approach for monitoring its activity and contribution to cellular redox control. NSJ Bioreagents provides a high-quality GLRX antibody validated for applications such as western blot, immunohistochemistry, and immunofluorescence. Choosing a GLRX antibody from NSJ Bioreagents ensures consistent performance and reproducibility in studies of oxidative stress, redox regulation, and disease mechanisms.